Zobrazeno 1 - 10 of 17 pro vyhledávání: '"Panepinto O"'
1
Akademický článek
Changes in clinical presentation, management, and survival outcomes in patients affected by colorectal cancer following COVID-19 pandemic.
Autor: Parisi A; Department of Oncology, Università Politecnica delle Marche, Azienda Ospedaliera Universitaria delle Marche, Ancona 60126, Italy., Giampieri R; Department of Oncology, Università Politecnica delle Marche, Azienda Ospedaliera Universitaria delle Marche, Ancona 60126, Italy., Villani S; Department of Oncology, Università Politecnica delle Marche, Azienda Ospedaliera Universitaria delle Marche, Ancona 60126, Italy., Magnarini A; Department of Oncology, Università Politecnica delle Marche, Azienda Ospedaliera Universitaria delle Marche, Ancona 60126, Italy., Gelsomino F; Department of Oncology and Hematology, University Hospital of Modena, Modena 41125, Italy., Traisci D; Medical Oncology, Ospedale San Pio da Pietrelcina, ASL 2 Abruzzo, Vasto 66054, Italy., Barbin F; Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan 20122, Italy., Salvatore L; Comprehensive Cancer Center, Fondazione Policlinico Universitario 'A Gemelli'-IRCCS, Rome 00168, Italy.; Medical Oncology, Catholic University of Sacred Heart, Rome, Italy., Zichi C; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin 10128, Italy., Di Pietro FR; U.O.C. Oncologia, Istituto Dermopatico dell'Immacolata IDI-IRCCS  00167, Roma, Italy., Zoratto F; Medical Oncology Unit, Ospedale 'S.M. Goretti'-ASL Latina  04100, Latina, Italy., Lanese A; UOC Oncologia Medica, Ospedale A. Murri  63900, Fermo, Italy., Petrillo A; Medical Oncology Unit, Ospedale del Mare, Naples, Italy., Zurlo IV; Medical Oncology, 'Vito Fazzi' Hospital, Lecce 80147, Italy., Spallanzani A; Department of Oncology and Hematology, University Hospital of Modena, Modena 41125, Italy., D'Ostilio N; Medical Oncology, Ospedale San Pio da Pietrelcina, ASL 2 Abruzzo, Vasto 66054, Italy., Ghidini M; Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan 20122, Italy., Bensi M; Medical Oncology, Catholic University of Sacred Heart, Rome, Italy., Schietroma F; Medical Oncology, Catholic University of Sacred Heart, Rome, Italy., Rognone C; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin 10128, Italy., Panepinto O; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin 10128, Italy., Paparo J; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin 10128, Italy., Gamba T; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin 10128, Italy., Bisonni R; UOC Oncologia Medica, Ospedale A. Murri  63900, Fermo, Italy., Di Lorenzo S; Medical Oncology Unit, Ospedale del Mare, Naples, Italy., Daniele B; Medical Oncology Unit, Ospedale del Mare, Naples, Italy., Mentrasti G; Department of Oncology, Università Politecnica delle Marche, Azienda Ospedaliera Universitaria delle Marche, Ancona 60126, Italy., Berardi R; Department of Oncology, Università Politecnica delle Marche, Azienda Ospedaliera Universitaria delle Marche, Ancona 60126, Italy.
Publikováno v: The oncologist [Oncologist] 2024 Nov 26. Date of Electronic Publication: 2024 Nov 26.
Zobrazit plný text záznamu
2
Akademický článek
Health-related quality of life assessment in head and neck cancer: A systematic review of phase II and III clinical trials.
Autor: Filippini DM; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy., Carosi F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy., Panepinto O; Department of Oncology, University of Turin, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Neri G; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy., Nobili E; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy., Tober N; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.; Azienda Ospedaliera Maggiore Della Caritá, Novara, Italy., Giusti R; Medical Oncology Unit, Sant'Andrea Hospital of Rome, Italy., Di Maio M; Department of Oncology, University of Turin, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
Publikováno v: Heliyon [Heliyon] 2024 Nov 24; Vol. 10 (23), pp. e40671. Date of Electronic Publication: 2024 Nov 24 (Print Publication: 2024).
Zobrazit plný text záznamu
3
Akademický článek
Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Urothelial Cancer.
Autor: Gamba T; Department of Oncology, University of Turin, AO Ordine Mauriziano Hospital, Turin, Italy., Paparo J; Department of Oncology, University of Turin, AO Ordine Mauriziano Hospital, Turin, Italy., Panepinto O; Department of Oncology, University of Turin, AO Ordine Mauriziano Hospital, Turin, Italy., Dionisio R; Division of Medical Oncology, AO Ordine Mauriziano Hospital, Turin, Italy., Di Maio M; Department of Oncology, University of Turin, AO Ordine Mauriziano Hospital, Turin, Italy. Electronic address: massimo.dimaio@unito.it., Vignani F; Division of Medical Oncology, AO Ordine Mauriziano Hospital, Turin, Italy.
Publikováno v: Clinical genitourinary cancer [Clin Genitourin Cancer] 2023 Oct; Vol. 21 (5), pp. 509-516. Date of Electronic Publication: 2023 Jul 20.
Zobrazit plný text záznamu
4
Akademický článek
Frequency of Germline and Somatic BRCA1 and BRCA2 Mutations in Prostate Cancer: An Updated Systematic Review and Meta-Analysis.
Autor: Valsecchi AA; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, 10128 Turin, Italy., Dionisio R; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, 10128 Turin, Italy., Panepinto O; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, 10128 Turin, Italy., Paparo J; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, 10128 Turin, Italy., Palicelli A; Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy., Vignani F; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, 10128 Turin, Italy., Di Maio M; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, 10128 Turin, Italy.
Publikováno v: Cancers [Cancers (Basel)] 2023 Apr 24; Vol. 15 (9). Date of Electronic Publication: 2023 Apr 24.
Zobrazit plný text záznamu
5
Akademický článek
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study.
Autor: Rebuzzi SE; Medical Oncology Unit, Ospedale San Paolo, 17100 Savona, Italy.; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, 16132 Genoa, Italy., Brunelli M; Pathology Unit, Department of Diagnostics and Public Health, University and Hospital Trust of Verona, 37124 Verona, Italy., Galuppini F; Surgical Pathology Unit, Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy., Vellone VG; Pathology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy., Signori A; Department of Health Sciences (DISSAL), Section of Biostatistics, University of Genoa, 16132 Genoa, Italy., Catalano F; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy., Damassi A; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy., Gaggero G; Pathology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy., Rescigno P; Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.; Translational and Clinical Research Institute, Centre for Cancer, Newcastle University, Newcastle upon Tyne NE1 7RU, UK., Maruzzo M; Oncology Unit 1, Istituto Oncologico Veneto IOV-IRCCS, 35128 Padua, Italy., Merler S; Section of Oncology, Department of Medicine, University of Verona and Verona University Hospital Trust, 37134 Verona, Italy., Vignani F; Division of Medical Oncology, Ordine Mauriziano Hospital, 10128 Turin, Italy., Cavo A; Oncology Unit, Villa Scassi Hospital, 16149 Genoa, Italy., Basso U; Oncology Unit 1, Istituto Oncologico Veneto IOV-IRCCS, 35128 Padua, Italy., Milella M; Section of Oncology, Department of Medicine, University of Verona and Verona University Hospital Trust, 37134 Verona, Italy., Panepinto O; Division of Medical Oncology, Ordine Mauriziano Hospital, 10128 Turin, Italy., Mencoboni M; Oncology Unit, Villa Scassi Hospital, 16149 Genoa, Italy., Sbaraglia M; Surgical Pathology Unit, Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy., Dei Tos AP; Surgical Pathology Unit, Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy., Murianni V; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy., Cremante M; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy., Llaja Obispo MA; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy., Maffezzoli M; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy., Banna GL; Department of Oncology, Portsmouth Hospitals University NHS Trust, Portsmouth PO6 3LY, UK., Buti S; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy., Fornarini G; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.
Publikováno v: Cancers [Cancers (Basel)] 2023 Apr 21; Vol. 15 (8). Date of Electronic Publication: 2023 Apr 21.
Zobrazit plný text záznamu
6
Akademický článek
Cancer cell-selective induction of mitochondrial stress and immunogenic cell death by PT-112 in human prostate cell lines.
Autor: Soler-Agesta, R.1 (AUTHOR), Moreno-Loshuertos, R.1 (AUTHOR) raquelml@unizar.es, Yim, C. Y.2 (AUTHOR), Congenie, M. T.2 (AUTHOR), Ames, T. D.2 (AUTHOR), Johnson, H. L.3 (AUTHOR), Stossi, F.3 (AUTHOR), Mancini, M. G.3 (AUTHOR), Mancini, M. A.3 (AUTHOR), Ripollés-Yuba, C.1 (AUTHOR), Marco-Brualla, J.1 (AUTHOR), Junquera, C.4 (AUTHOR), Martínez-De-Mena, R.5 (AUTHOR), Enríquez, J. A.5 (AUTHOR), Price, M. R.2 (AUTHOR), Jimeno, J.1,2 (AUTHOR), Anel, A.1 (AUTHOR) anel@unizar.es
Publikováno v: Journal of Translational Medicine. 10/11/2024, Vol. 22 Issue 1, p1-17. 17p.
Zobrazit plný text záznamu
7
Akademický článek
Androgen Insensitivity Syndrome with Bilateral Gonadal Sertoli Cell Lesions, Sertoli–Leydig Cell Tumor, and Paratesticular Leiomyoma: A Case Report and First Systematic Literature Review.
Autor: Karseladze, Apollon I.1 (AUTHOR), Asaturova, Aleksandra V.2 (AUTHOR) a.asaturova@gmail.com, Kiseleva, Irina A.3 (AUTHOR), Badlaeva, Alina S.2 (AUTHOR), Tregubova, Anna V.2 (AUTHOR), Zaretsky, Andrew R.4 (AUTHOR) a-zaretsky@yandex.ru, Uvarova, Elena V.3 (AUTHOR), Zanelli, Magda5 (AUTHOR) magda.zanelli@ausl.re.it, Palicelli, Andrea5 (AUTHOR)
Publikováno v: Journal of Clinical Medicine. Feb2024, Vol. 13 Issue 4, p929. 33p.
Zobrazit plný text záznamu
9
Akademický článek
Single-center analysis of a real-world cohort of patients with metastatic urothelial carcinoma evaluated by NGS: molecular landscape and efficacy of targeted therapies.
Autor: Gutiérrez Pérez C; Department of Medical Oncology, Hospital Universitario de Burgos (HUBU), Av. Islas Baleares, 3, 09006, Burgos, Spain. cesargutierrezperez@hotmail.com., Lastra Aras E; Department of Medical Oncology, Hospital Universitario de Burgos (HUBU), Av. Islas Baleares, 3, 09006, Burgos, Spain., Saiz López P; Department of Anatomic Pathology, Hospital Universitario de Burgos (HUBU), Burgos, Spain., García Toro E; Department of Anatomic Pathology, Hospital Universitario de Burgos (HUBU), Burgos, Spain., Blanco Abad C; Department of Medical Oncology, Hospital Universitario de Burgos (HUBU), Av. Islas Baleares, 3, 09006, Burgos, Spain., Rodríguez Ledesma I; Department of Medical Oncology, Hospital Universitario de Burgos (HUBU), Av. Islas Baleares, 3, 09006, Burgos, Spain., Pumares González M; Department of Medical Oncology, Hospital Universitario de Burgos (HUBU), Av. Islas Baleares, 3, 09006, Burgos, Spain., Vela Domínguez M; Department of Medical Oncology, Hospital Universitario de Burgos (HUBU), Av. Islas Baleares, 3, 09006, Burgos, Spain., Espinosa Cabria N; Department of Medical Oncology, Hospital Universitario de Burgos (HUBU), Av. Islas Baleares, 3, 09006, Burgos, Spain., Crespo Herrero G; Department of Medical Oncology, Hospital Universitario de Burgos (HUBU), Av. Islas Baleares, 3, 09006, Burgos, Spain.
Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Aug 15. Date of Electronic Publication: 2024 Aug 15.
Zobrazit plný text záznamu
10
Akademický článek
How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma?
Autor: Conci N; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Tassinari E; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Tateo V; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Rosellini M; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Marchetti A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Ricci C; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.; Pathology Unit, Maggiore Hospital-AUSL Bologna, Bologna, Italy., Chessa F; Division of Urology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Santoni M; Oncology Unit, Macerata Hospital, Macerata, Italy., Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain., Mollica V; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy. francesco.massari@aosp.bo.it.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy. francesco.massari@aosp.bo.it.
Publikováno v: Molecular diagnosis & therapy [Mol Diagn Ther] 2024 Jan; Vol. 28 (1), pp. 37-51. Date of Electronic Publication: 2023 Oct 24.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje